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Abstract: Introduction: The objective of the analysis was to determine the epidemiology of healthcare-
associated infections (HAIs) in neurosurgical patients, paying special attention to two time points,
2003 and 2017, in order to evaluate the effectiveness of a surveillance program introduced in
2003 and efforts to reduce infection rates. Materials and methods: Continuous surveillance during
2003–2017 carried out using the HAI-Net methodology allowed us to detect 476 cases of HAIs among
10,332 patients staying in a 42-bed neurosurgery unit. The intervention in this before–after study
(2003–2017) comprised standardized HAI surveillance with regular analysis and feedback. Results:
The HAI incidence during the whole study was 4.6%. Surgical site infections (SSIs) accounted for
33% of all HAIs with an incidence rate of 1.5%. The remaining infections were pneumonia (1.1%)
and bloodstream infections (0.9%). The highest SSI incidence concerned spinal fusion (FUSN, 2.2%),
craniotomy (1.9%), and ventricular shunt (5.1%) while the associated total HAI incidence rates were
4.1%, 8.0%, and 18.6%, respectively. A significant reduction was found in HAI incidence between
2003 and 2017 in regard to the most common surgery types: laminectomy (4.5% vs. 0.8%); FUSN
(11.8% vs. 0.8%); and craniotomy (10.1% vs. 0.4%). Significant changes were also achieved in
selected elements of the unit’s work: pre-hospitalization duration, hospital stay, and surgery length
reductions. Simultaneously, the general condition of patients became significantly worse: there was
an increase in patients’ age and decreases in their general condition as expressed by ASA scores
(The American Society of Anesthesiologists physical status classification system). Conclusions: HAI
epidemiology changed substantially during the study period. Among the main types of HAI,
SSIs were slightly predominant, but non-surgical HAIs accounted for almost two thirds of all
infections; this indicates the need for surveillance of infection types other than SSIs in surgical
patients. The implementation of active surveillance based on regular analysis and feedback led to
a significant reduction in HAI incidence.
Keywords: neurosurgery; surgical site infections; spinal surgery; craniotomy; laminectomy
1. Introduction
Healthcare-associated infections (HAIs) and, particularly, the associated problem of antibiotic
resistance are indicated by WHO as one of the most important challenges of modern medicine.
WHO recommend a multimodal strategy for implementing infection prevention and control activities.
This consists of several elements or components: monitoring practices, processes and outcomes,
providing data feedback, and education of health care workers, among others. Monitoring or wider
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surveillance—the systematic collection, analysis, and interpretation of health data—is essential for the
planning, implementation, and evaluation of public health practice. Health care facility surveillance
should be based on standard definitions and methods and provide information for describing the
epidemiology and microbiology of HAIs [1]. The scope of this control may vary, as well as the
methods. The European Centre for Disease Prevention and Control (ECDC) recommends active
surveillance of infections in intensive care units and of surgical site infections (SSIs) in selected surgical
procedures [2]. Consequently, the epidemiological situation is well known and described regarding
these recommended forms of surveillance. However, a thorough analysis of the data coming from
an active but also comprehensive program of HAI surveillance in a Polish multi-profile hospital has
demonstrated that active surveillance should additionally encompass patients from departments other
than intensive care units and, depending on the needs of a given facility, those undergoing different
surgical procedures [3]. This is particularly important in poorly described neurosurgery: studies on
HAIs in neurosurgery are rarely undertaken or published, including in Poland.
Nevertheless, there are limited data available on both the incidence and burden of HAIs (all types
of HAIs) in neurosurgical patients of hospitals in Central Europe, but several reports from different
parts of the world confirm that the risk of HAIs in study populations is high, reaching 6.7% in India
and 3.6% in a Turkish neurosurgical intensive care unit (ICU) [4,5]. Patients requiring neurosurgical
treatment are at a higher risk of developing HAIs, both surgical site infections and other forms, due
to the risk of impaired protective reflexes, increased application of invasive medical devices, longer
hospital stay, and altered consciousness [4,6].
Carrying out continuous, targeted surveillance is an essential element that allows us to determine the
current epidemiological situation of the unit and implement preventive actions. Therefore, the objective of
this analysis was to determine both the epidemiology and microbiology of neurosurgical patients’ infections,
as well as trends in their occurrence between 2003 (the beginning of HAI surveillance) and 2017, in order to
evaluate the effectiveness of measures implemented in the field of infection prevention.
2. Materials and Methods
2.1. Setting
An intervention study using surveillance of HAIs, observation, and feedback was carried out in
a neurosurgical unit in St. Luke Provincial Hospital in Tarnów, Poland, in 2003–2017. The department
offers 42 hospital beds (including 6 intensive care beds with mechanical ventilation). Patients in very
poor clinical condition do not stay in this department as they are generally sent to a separate general
intensive care unit. Active surveillance of infections was implemented in the hospital in 2001, and the
experiences concerning the neurosurgery unit were already the subject of previous general analyses
not including trend analysis or detailed analyses of various HAI clinical forms [7]. The Infection
Control Team (ICT) consists of a doctor and four full-time epidemiological nurses.
2.2. Outcome Measurement Methodology
The data analyzed the time when the studied unit introduced targeted and active HAI
surveillance, initially (2003–2012), using tools, definitions, and protocols in accordance with the
National Healthcare Safety Network (NHSN) [8]. Then, from 2012, the HAI recognition methodology
and HAI record-keeping followed the Surveillance Network (HAI-Net) by the European Centre for
Disease Prevention and Control (ECDC) [9,10]. For the purposes of this analysis, HAI cases originally
qualified according to the NHSN criteria were retrospectively subjected to reclassification according to
the ECDC definitions; hence, all HAI cases were qualified into individual HAI categories according
to the ECDC case definition, keeping the divisions into catheter-related bloodstream infection (BSI)
and BSI secondary to another infection, five subcategories of pneumonia (PN), and three forms of SSI.
The surgeries performed were stratified by type of operation conforming to ICD 9-CM, according to
the NHSN code (Table 1).
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Table 1. List of surgeries and ICD-9 codes.
Code Operative Procedure ICD-9
LAM
Laminectomy: exploration or
decompression of spinal cord through
excision or incision into vertebral structures
03.01; 03.02; 03.09; 80.50; 80.5; 80.53; 80.54; 80.59;
84.60–84.69; 84.80–84.85.
FUSN Spinal implant surgery: spinal fusion,Immobilization of spinal column 81.00–81.08
CRAN
Craniotomy: incision through the skull to
excise, repair, or explore the brain; does not
include taps or punctures
01.12; 01.14; 01.20–01.25; 01.28; 01.29; 01.31; 01.32;
01.39; 01.41; 01.42; 01.51–01.53; 01.59; 02.11–02.14;
02.91–02.93; 07.51–07.54; 07.59; 07.61–07.65; 07.68;
07.69; 07.71; 07.72; 07.79; 38.01; 38.11; 38.31; 38.41;
38.51; 38.61; 38,81; 39.28.
VP Shunt VP shunt: ventricular shunt operations,including revision and removal of shunt 02.21; 02.22; 02.31–02.35; 02.39; 02.42; 02.43; 54.95.
2.3. Bacterial Isolates
A single strain was derived from the first sample collected in the case of the first episode of HAI,
and to confirm a diagnosis of BSI, at least two blood samples were taken. The strains were identified
using BD Phoenix NID panels from the automated Phoenix 100 Becton Dickinson Diagnostic System
(Becton Dickinson, Warsaw, Poland) according to the manufacturer’s instructions. All materials taken
from gastrointestinal tract infections were tested for Shigella spp., Salmonella spp., rotavirus, norovirus,
adenovirus, and Clostridium difficile (CD), and a general stool culture was performed.
2.4. Process Improvement Indicators
Beginning in 2003, changes were being implemented regarding HAI prevention and control by
the ICT together with the staff of the departments (neurosurgery, operating room, and ICT); among
other changes, these included the following:
1. Hospital admission rules for shortening the pre-operative stay and optimal patient preparation
for surgery to limit emergency surgery; preparation of the surgical team, including
a. diagnostics and qualification for surgery as far as possible in an outpatient procedure
without prior hospitalization before surgery,
b. pre-operative screening at a preoperative assessment clinic and the decolonization of
methicillin-resistant Staphylococcus aureus (MRSA) in elective procedures.
2. Perioperative procedures for patient preparation for surgery, including
a. hair removal: cutting instead of shaving,
b. bathing immediately prior to surgery,
c. changing bed linens and patient’s clothing immediately before surgery.
3. Work organization of the operating block, including
a. preoperative checklist,
b. surgical hand hygiene according to WHO guidelines,
c. preparation of the operating field and surgical drape,
d. application of antiseptic to the edges of the wound before sewing it.
4. Patient care during the postoperative period:
a. the five moments for hand hygiene,
b. post-operative dressing and wound control.
5. Active surveillance of all forms of HAIs:
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a. systematic collection, analysis, and interpretation of data for evaluation of practices,
b. yearly feedback on the epidemiology and microbiology of HAIs,
c. regular feedback on compliance with the procedures described above and hand hygiene.
In addition, regular education and training of health care workers based on the results of the
surveillance were also implemented. Implementation of procedures and surveillance with analysis and
feedback aimed at preventing SSIs were initiated by the ICT and concerned all operational procedures
without distinguishing the type of surgery in accordance with global guidelines.
2.5. Statistical Analysis
In order to carry out an evaluation of the epidemiological situation, the following epidemiological
indicator was applied: the cumulative incidence of HAI, defined as the number of HAI cases divided
by the number of neurosurgery procedures × 100. Statistical analysis of the collected material
employed IBM SPSS (SPSS—Statistical Package for the Social Sciences) software, STATISTICS 24,
Armonk, NY, USA, and Microsoft Excel, Microsoft Office, 2016, Redmond, WA, USA. Statistical
analysis was carried out with the use of basic statistical parameters, i.e., mean, standard deviation,
95% confidence intervals for the mean, and median. In order to compare the frequency of occurrence
of qualitative feature variants, Pearson’s chi-square test of independence was applied; for variables
in small quantities, Fisher’s exact test; and for quantitative variables, we used ANOVA. The level of
significance was p < 0.05.
The use of data was approved by the Bioethical Committee of the Jagiellonian University
(No. KBET/122.6120.118.2016 from May 25, 2016). All the data entered into the electronic database
and analyzed in this study were previously anonymized. The work has been reported in line with the
Standards for Quality Improvement Reporting Excellence (SQUIRE) criteria. The study was registered
at http://www.clinicaltrials.gov, Identifier: NCT03686553.
3. Results
The total number of patients covered by the study amounted to 10,332 people operated upon in
the neurosurgical unit in the study period of 15 years. In total, 476 HAIs were detected, and the total
incidence rate was 4.6%. During the study (total, from 2003 to 2017) SSIs accounted for 33% of all HAIs:
157 cases (incidence 1.5%) (Table 2). The highest HAI incidence rates were observed with operations
performed on the brain, i.e., ventricular shunt implantation surge (VP shunt, 77 cases, 18.6%) and
craniotomy (235 cases, 8.0%). As for spinal surgery, the HAI incidence rates were significantly lower,
i.e., 4.1% in spinal fusion (FUSN) (98 cases) and 1.4% in laminectomy (66 cases) (Table 2). Non-surgical
infections accounted for 67% of all HAIs and were most often pneumonia (118 cases, 24.8% of all HAIs)
and BSI (97, 20.4%). The PN incidence in patients needing mechanical ventilation (ventilator-associated
pneumonia, VAP) was 40.5/1000 days of mechanical ventilation, and the incidence in patients with
central line–associated bloodstream infections (CLA-BSI) was 3.3/1000 catheter days.
Table 2. Incidence of hospital-acquired infections (HAIs) by major and specific site of infection in the
years 2003–2017.
Surgery Type (N = 10,332)
LAM
(n = 4571)
FUSN
(n = 2397)
CRAN
(n = 2950)
VP Shunt
(n = 414) Incidence Share in the
Total Pool of
HAIs (%)All HAIs (n = 476) 66 98 235 77
HAI Incidence (%) 1.4 4.1 8.0 18.6 4.6
Surgical site infection (n = 157)
SSI incidence (%)
33.0
0.6 2.2 1.9 5.1 1.52
superficial incisional (n = 56) 11 21 22 2 0.54
deep incisional (n = 90) 16 31 30 13 0.87
organ/space (n = 11) 0 0 5 6 0.11
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Table 2. Cont.
Surgery Type (N = 10,332)
LAM
(n = 4571)
FUSN
(n = 2397)
CRAN
(n = 2950)
VP Shunt
(n = 414) Incidence Share in the
Total Pool of
HAIs (%)All HAIs (n = 476) 66 98 235 77
HAI Incidence (%) 1.4 4.1 8.0 18.6 4.6
Pneumonia (PN) (n = 118)
PN incidence (%)
24.8
0.1 0.4 2.7 5.6 1.14
PN1 (n = 2) 0 0 2 0 0.02
PN2 (n = 8) 2 0 1 5 0.08
PN3 (n = 0) 0 0 0 0 0.00
PN4 (n = 70) 4 6 46 14 0.68
PN5 (n = 38) 0 3 31 4 0.37
Bloodstream infections (BSI)
(n = 97)
BSI incidence (%)
20.4
0.2 0.8 1.8 4.1 0.94
BSI: catheter related (n = 23) 0 1 17 5 0.22
BSI: unknown origin (n = 44) 5 14 18 7 0.43
sepsis (n = 3) 0 0 3 0 0.03
BSI: secondary (n = 27) 4 3 15 5 0.26
Urinary tract infection (n = 63)
UTI incidence (%)
13.2
0.3 0.3 0.9 3.1 0.61
microbiologically
confirmed
yes (n = 54) 8 6 27 13 0.52
no (n = 9) 6 2 1 0 0.09
Gastrointestinal (n = 33)
GI incidence (%)
6.9
0.2 0.4 0.4 0.7 0.32
Clostridium difficile infection
(n = 9) 2 1 4 2 0.09
Gastroenteritis (n = 24) 6 8 9 1 0.23
Skin and soft tissue infection
(n = 8)
SST incidence (%)
1.70.0 0.0 0.1 0.0 0.08
skin infection (n = 8) 2 2 4 0 0.08
Legend: LAM, laminectomy; FUSN, spinal implant surgery; CRAN, craniotomy; VP shunt, ventricular shunt
implantation surgery; PN1, positive quantitative culture of material from minimally contaminated of secretions
from the lower respiratory tract (LRT); PN2, positive quantitative culture of material from possibly contaminated
LRT; PN3, pneumonia confirmed microbiologically using alternative methods; PN4, positive qualitative culture of
sputum or secretions from the respiratory tract; PN5, non-microbiologically-confirmed pneumonia.
A significant reduction was found in HAI incidence before (2003) and after the implementation of
surveillance (2017) regarding the most commonly performed types of procedures, i.e., laminectomy,
4.5% vs. 0.8% (relative risk (RR) 5.5, 95% confidence interval (CI) 1.57–19.16, p = 0.01); FUSN, 11.8%
vs. 0.8% (RR 13.4, 95% CI 2.53–70.51, p < 0.001); craniotomy, 10.1% vs. 0.4% (25.3, 95% CI 2.87–170.58,
p < 0.001); and VP shunt, 23.1% vs. 11.1% (1.8, 95% CI 0.43–8.24, p = 0.648) (Table 3).
As a result of the activities conducted, a significant change was achieved regarding selected
elements of the unit’s work, i.e., there was a decrease in the duration of hospitalization before surgery
(FUSN and craniotomy), as well as in the length of hospital stay (FUSN and craniotomy) and surgery
duration (laminectomy and VP shunt), and the number of urgent surgeries was limited in favor
of better preparation for planned procedures in craniotomy (Table 3). At the same time, there was
a significant deterioration in the demographics of the patients operated: the patients’ age (laminectomy
and craniotomy) and their general condition as expressed by ASA score (ASA 1–2 pts vs. ASA 3–4 pts)
(laminectomy, FUSN, craniotomy) increased.
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Table 3. Characteristics of patients (with and without HAIs) and their hospitalization in two phases of the observational period: before (2003) and after (2017)
implementation of active surveillance of hospital-acquired infections (HAIs).
Surgery Type Spinal Surgery Brain Surgery
LAM FUSN CRAN VP Shunt
Phase of the Study Before After Before After Before After Before After
surgeries, no. 133 504 34 252 99 240 13 27
HAI, no. 6 4 4 2 10 1 3 3
HAI incidence (%) 4.5 0.8 11.8 0.8 10.1 0.4 23.1 11.1
RR 95%CI, Fisher’s exact test (p) 5.5, 1.57–19.16, p = 0.01 13.4, 2.53–70.51, p < 0.001 25.3, 2.87–170.58, p < 0.001 2.1, 0.43–8.24, p = 0.648
Patient age (years)
Mean (SD) 48 (13.8) 52 (14.5) 52 (13.1) 51 (14.5) 56 (16.9) 61 (16.4) 57 (14.7) 54 (20.4)
ANOVA (p) p = 0.005 p = 0.647 p = 0.031 p = 0.611
Hospitalization duration prior to surgery (days)
Mean (SD) 6 (5.041) 3 (2.696) 8 (6.569) 4 (4.022) 4 (5.9) 3 (4.8) 9 (9.8) 9 (12.6)
ANOVA (p) p < 0.001 p < 0.001 p = 0.150 p = 0.857
Hospitalization duration (days)
Mean (SD) 13 (8.3) 9 (5.4) 20 (21.5) 11 (12.1) 14 (13.8) 13 (10.8) 19 (14.9) 20 (22.2)
ANOVA (p) p < 0.001 p < 0.001 p = 0.406 p = 0.885
Surgery duration (minutes)
\Mean (SD) 127 (55.5) 116 (55.6) 135 (39.6) 141 (65.7) 110 (46.3) 88 (56.4) 80 (21.7) 65 (31.1)
ANOVA (p) p = 0.043 p = 0.027 p = 0.001 p = 0.043
Sex
Men 85 (63.9%) 280 (55.6%) 17 (50.0%) 138 (54.8%) 66 (66.7%) 147 (61.2%) 8 (61.5%) 16 (59.3%)
Women 48 (36.1%) 224 (44.4%) 17 (50.0%) 114 (45.2%) 33 (33.3%) 93 (38.8%) 5 (38.5%) 11 (40.7%)
Fisher’s exact test (p) p = 0.051 p = 0.366 p = 0.208 p = 0.585
Operation mode
Planned 132 (99.2%) 471 (93.5%) 34 (100.0%) 234 (92.9%) 23 (23.2%) 107 (44.6%) 13 (100.0%) 21 (77.8%)
Urgent 1 (0.8%) 33 (6.5%) 0 (0.0%) 18 (7.1%) 76 (76.8%) 133 (55.4%) 0 (0.0%) 6 (22.2%)
Fisher’s exact test (p) p = 0.003 p = 0.095 p < 0.001 p = 0.077
Patient condition according to the ASA score
ASA 1–2 pts 61 (45.9%) 159 (31.5%) 16 (47.1%) 88 (34.9%) 20 (20.2%) 23 (9.7%) 1 (7.7%) 1 (3.7%)
ASA 3–5 pts 72 (54.1%) 345 (68.5%) 18 (52.9%) 164 (65.1%) 79 (79.8%) 215 (90.3%) 12 (92.3%) 26 (96.3%)
Fisher’s exact test (p) p < 0.001 p = 0.008 p < 0.001 p = 0.978
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HAI epidemiology, unit work indicators, and patients’ characteristics following infrequently
performed VP shunt procedures did not change (Table 3).
HAI microbiology was dominated by Gram-positive cocci (35.9%), mainly Staphylococcus aureus
(120 cases, 25.2%), which was also the most common etiologic agent in SSIs (78 cases, 49.7%). In BSIs,
coagulase-negative staphylococci (28 cases, 28.9%) were most frequently encountered. In pneumonia,
Acinetobacter baumannii (26 isolates, 22.0%) was most often isolated. In total, 72 cases of HAIs (15.1%)
lacked microbiological confirmation of various HAIs, and confirmation was obtained less frequently
in the cases of pneumonia and gastrointestinal infection, of which only 70.3% and 27.3%, respectively,
were microbiologically confirmed (Table 4).
Table 4. Etiology of different types of HAIs, 2003–2017.
Microorganism
BSI GI PN SSI SST UTI Total
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Gram-positive cocci
Staphylococcus aureus 24 (24.7) 0 (0.0%) 13 (11.0) 78 (49.7) 4 (50.0) 1 (1.6) 120(25.2)
Coagulase-negative staphylococci 28 (28.9) 0 (0.0%) 0 (0.0%) 5 (3.2) 1 (12.5) 34 (7.1)
Streptococcus spp. 0 (0.0%) 0 (0.0%) 5 (4.2) 3 (1.9) 0 (0.0%) 9 (14.3) 17 (3.6)
Enterobacteriaceae
Escherichia coli 10 (10.3) 0 (0.0%) 5 (4.2) 9 (5.7) 0 (0.0%) 19 (30.2) 43 (9.0)
Klebsiella spp. 7 (7.2) 0 (0.0%) 13 (11.0) 2 (1.3) 0 (0.0%) 7 (11.1) 29 (6.1)
Enterobacter spp. 7 (7.2) 0 (0.0%) 5 (4.2) 18 (11.5) 1 (12.5) 1 (1.6) 32 (6.7)
Proteus spp. 2 (2.1) 0 (0.0%) 7 (5.9) 0 (0.0%) 0 (0.0%) 5 (7.9) 14 (2.9)
Serratia spp. 3 (3.1) 0 (0.0%) 0 (0.0%) 2 (1.3) 0 (0.0%) 5 (1.1)
Non-fermenting Gram-negative bacteria
Acinetobacter baumannii 11 (11.3) 0 (0.0%) 26 (22.0) 24 (15.3) 1 (12.5) 4 (6.3) 66 (13.9)
Pseudomonas aeruginosa 0 (0.0%) 0 (0.0%) 6 (5.1) 7 (4.5) 1 (12.5) 6 (9.5) 20 (4.2)
Morganella morganii 0 (0.0%) 0 (0.0%) 3 (2.5) 1 (0.6) 0 (0.0%) 1 (1.6) 5 (1.1)
Others
Clostridium difficile 0 (0.0%) 9 (27.3) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 9 (1.9)
Candida spp. 2 (2.1) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 8 (12.7) 10 (2.1)
Non-microbiologically-confirmed 3 (3.1) 24 (72.7) 35 (29.7) 8 (5.1) 0 (0.0%) 2 (3.2) 72 (15.1)
Total 97 (100) 33 (100) 118 (100) 157 (100) 8 (100) 63 (100) 476 (100)
4. Discussion
In the studied neurosurgical unit, SSI incidence amounted to 1.5% and was close to expectations;
other authors report it at levels of 1.3% (95% CI 1.1–1.5) in Europe 2008–2009, with an inter-country range
of 0.4%–6.3%, or 2.2% (RR 11.3, 95% CI 4.2–30.6; p < 0.01) in Italy in 2002–2004, among others [11–14].
Nevertheless, to confirm the effectiveness of the ICT and the sensitivity of infection prevention, it is relevant
that SSI characteristics, i.e., the dominance of deep incisional infections, which accounted for more than half
of the cases, are confirmed in the literature since a similar result of 62% of deep incisional infections among
all SSIs was obtained by Smith [15].
In the period studied, the majority of surgeries were performed within the spine, i.e., laminectomy
or FUSN. The SSI incidence in laminectomy amounted to 0.6% and was one of the lowest among the
European countries that implement the European HAI-Net program (mean 1.3%, ranging from 0.4%
in Portugal to 6.3% in Hungary) [16]. Notably, during the implementation of surveillance for this
procedure type (between 2003–2017), HAI risk, including SSI, was significantly reduced. On the other
hand, analysis of patient demographics reveals some differences between the study population and
patients in Europe: the age of operated patients was lower than the age of operated patients in HAI-Net
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(49 years vs. 54 years). This is probably due to using less strict criteria for surgical interventions or
to the health condition of Polish patients who require surgical intervention earlier than is the case
in other European countries [16], which appears to be associated with better functional capacities of
younger patients, reducing susceptibility to SSI, resulting in low incidence.
Research into SSIs following spinal fusion (FUSN) indicates a high similarity to the data presented
by other authors. In American multicenter NHSN studies from 2006 to 2008, values close to ours were
obtained, i.e., the median ranged from 0.7% to 4.2% [17,18], despite the fact that single-center data quote
incidence rates reaching 12% [15,19,20]. It was no different in the case of craniotomy, for which in an NHSN
program (data from 2006–2008), the median incidence was 2.9% [17], although Zhan et al. gave a much
higher value of 7.4% [21].
However, following the rarely performed VP shunt surgeries, SSI incidence in our study was
high and corresponded to the incidence in patients with multiple risk factors described in the NHSN
program, in which it reached 5.9% [17]; nevertheless, an even higher incidence is reported by Rosenthal,
who, on the basis of an analysis of data from 30 countries around the world, including from America,
Asia, Africa, and Europe, reported values as high as 12.9% [22].
The implementation of surveillance and infection prevention and control was of paramount
importance as it resulted in both measurable improvements in the organization of the unit and
functioning of the operating block and a reduction in the risk of HAI infections of all clinical forms,
in all procedures—with the exception of rarely performed VP shunts. This was particularly expressed
in the significant reduction in the durations of operations, e.g., in laminectomy; however, in 2017,
this value was much greater than the 75 min given in the European HAI-Net program [16], which may
be suggestive of a necessity to conduct further intensive works in this respect. Also, the length of
hospitalization obtained after the surveillance period (9 or 11 days, depending on the procedure type)
is still unsatisfactory—it is longer than, e.g., in Holland, where it is 6 days on average [23].
Surgery duration is pointed out as one of the most important parameters and a significant risk factor
for neurosurgical operations [24,25]. Therefore, given the importance of SSIs concerning patient outcomes
and health care economics, surgeons should focus their efforts on reducing operative time [26].
It is all the more significant that in the patient population observed, the characteristics of patients
changed significantly, especially regarding their age, which may indicate a trend of an aging patient
population and their increased susceptibility to infections. At the same time, the next property that
a researcher has no control over is sex: among the patients operated on, men were predominant,
and they are also usually more vulnerable to infections after neurosurgical procedures [27,28]. The fact
that being a man greatly affects the risk of SSI was also reported in Poland for thoracic procedures [29].
Owing to a comprehensive analysis of HAI data in the study population, it became clear that
non-surgical infections are very important and equally common among neurosurgical patients undergoing
surgery; among them, there were PN and BSI, which accounted for almost 2/3 of all HAIs, especially
following craniotomy. Particularly, VAP incidence was higher than expected: in neurosurgical intensive
care units in Italy, it was 4-fold lower [13], and in the NNIS program in 2006–2008, it was 8-fold
lower [17]. The situation is slightly better for CLA-BSI incidence, which is identical to that observed
in American neurosurgical ICUs [18]; however, it is simultaneously about two times higher than in Italy [13].
Such a comparison between the VAP incidence in the studied population and those in other neurosurgery
ICUs could be affected by the type and severity of treated neurosurgical diseases. Thus, drawing of
conclusions should be done with caution due to this limitation.
In our study, it is important to pay attention to the fact that in as many as 40% of BSI cases, it was
impossible to confirm the origin of infection. This situation may suggest a lack of an appropriate
approach to BSI diagnostics, which is unfortunately in line with the Polish national phenomenon,
because, even though we present single-center studies, a similar situation was confirmed in relation to
patients of Polish ICUs in a multicenter study [30]. The remaining types of infections were observed
relatively less frequently; however, a large number of non-microbiologically-confirmed gastroenteritis
cases, over 2/3, draws our attention.
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In an analysis of etiologic agents of infection, according to our expectations, it was confirmed
that BSIs were most often caused by Staphylococcus aureus and coagulase-negative staphylococci.
Pneumonia was most frequently brought about by Acinetobacter baumannii, but it should be noted that
as many as 54 (31%) cases of PN were not confirmed microbiologically. The situation is similar to the
one described in a multicenter study of Polish ICUs which showed the weaknesses of microbiological
diagnostics or lack of access to it [31]. Acinetobacter baumannii is not a common cause of pneumonia
in most European countries [32], but in recent years in Polish ICUs, a large burden of pneumonia by
Gram-negative bacilli has been documented with dominance of A. baumannii, which was responsible for
as many as 1 in 5 cases [31]. A. baumannii is not commonly regarded as a major pneumonia pathogen,
and because only a minority of pneumonia microbiological diagnoses were properly made in the
studied unit and also in many Polish ICUs, it is difficult to know whether the high prevalence
of A. baumannii may have resulted from inadequate diagnosis or environmental contamination,
e.g., stethoscopes can be a cause of cross-infection [33]. On the other hand, other authors have
also reported a high proportion of non-fermenting bacilli in infections in neurosurgical ICUs [34] and
in other surgical departments [35].
In SSIs, Staphylococcus aureus was predominant, and Escherichia coli was for urinary tract infections.
Clostridium difficile was seemingly dominant in gastrointestinal tract infections; however, in as many
as 63% of these infections, no infection factor was detected, or no such examinations were carried
out despite the availability of a full package of microbiological and virologic tests for diagnosing
these infections.
There are some limitations of the present study. Firstly, the research involves only one center.
Secondly, in the period studied, the infection detection method and compliance with the prevention
procedure were not systematically validated. Additionally, in 2012, the NHSN protocol changed to
ECDC; however, the authors’ assessment is that this did not influence the number of bloodstream
infections, pneumonia cases, and surgical site infections detected or qualified. It could only influence
the number of urinary tract infections qualified. The other limitation is the organization of the unit’s
work and the rule that patients in very poor clinical condition do not stay in this department as they
are generally sent to an intensive care unit; those patients were excluded from the analysis.
However, on the other hand, this study is unique regarding the reporting of HAIs in neurosurgery
with respect to Polish patients. The results of the analysis allow us to define the strengths and
weaknesses of infection surveillance and its priorities for the future. Firstly, intervention is required
regarding the high incidence of non-surgical infections, especially pneumonia and VAP, as well
as microbiological diagnostics of VAP. Secondly, it is essential to undertake actions to improve
the diagnostics of hospital-acquired bloodstream infections, pneumonia, and gastrointestinal tract
infections. The results presented show considerable (significant) differences in terms of both
epidemiological indicators and patient characteristics and the organization of the unit’s work between
2003 and 2017, which indicate that the surveillance of infections requires continuity and obtaining our
own reliable epidemiological data.
5. Conclusions
To conclude, the study has validated the usefulness of active surveillance of HAIs in neurosurgical
patients based on regular analysis and feedback. We suggest the implementation of infection control and
prevention based on evidence-based medicine. Such active SSI surveillance should be recommended by the
ECDC for the everyday activity of ICTs and should be adopted by other hospitals in Poland.
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ASA score American Society of Anesthesiologists system for assessing the fitness of patients before surgery
BSI bloodstream infection
CI confidence interval
CRAN craniotomy
ECDC European Centre for Disease Prevention and Control
FUSN spinal implant surgery
HAIs healthcare-associated infections
ICT Infection Control Team
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OR odds ratio
PN pneumonia
SSIs surgical site infections
VAP ventilator-associated pneumonia
VP shunt ventricular shunt implantation surgery
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